Skip to main content

Table 1 Summary of the studies that examined direct effects of propofol on breast cancer cells

From: Effect of Propofol on breast Cancer cell, the immune system, and patient outcome

Study

Cell line

[Propofol] (μg/ml)

Incubation time (hr)

Proliferation (method)

Migration (method)

Invasion (method)

Li et al

MDA-MB-231

2–10

24

 

↓ (wound healing)

↓ (Matrigel membrane)

Ecimovic et al

MDA-MB-231

6–10

24

No change (MTT)

↓ (8 μm pores)

No change (Matrigel membrane, 6 h)

Ecimovic et al

MCF7

4–10

24

No change (MTT)

↓ (8 μm pores)

↓ (Matrigel membrane, 6 h)

Yu et al

a MDA-MB-435

2 (10 μM)

6

↓ (TUNEL stain)

  

Siddiqui et al

MDA-MB-231

20 (100 μM)

24

↓ (WST-1)

No change (8 μm pores, 4 h, 5 μg/ml)

 

Garib et al

MDA-MB-468

3–9

10

 

↑ (collagen matrix, video tracking)

 

Meng et al

MDA-MB-231

2–10

12–24

↑ (MTT, 10 h)

↑ (wound healing)

 
  1. Note that propofol concentration and/or incubation time in a study may be different for different assays. This is noted in the Migration and Invasion columns
  2. aMDA-MB-435 is a cell line originated from a metastatic breast cancer but its identity could be melanoma instead